PMG-MAN and the Battle for Nigeria’s Pharma Independence -By Patrick Iwelunmor

There are certain battles that define the future of nations. Some are fought on political platforms. Others are fought in economic policies, industrial reforms and strategic investments. But perhaps one of the most important battles Nigeria must now fight is the battle for pharmaceutical independence.

For too long, Nigeria has depended heavily on imported medicines and pharmaceutical products to sustain its healthcare system. From essential drugs to critical raw materials, the country has remained vulnerable to global supply chain disruptions, foreign exchange instability and external market forces beyond its control.

This dependence has come at a cost. Every fluctuation in exchange rates affects the prices Nigerians pay for medicines. Every global crisis threatens access to lifesaving drugs. Every disruption in international shipping exposes the dangerous fragility of a healthcare system tied too closely to foreign production. The truth is simple: no nation can claim healthcare security while relying predominantly on other countries to manufacture its medicines.

This is why the growing campaign by the Pharmaceutical Manufacturing Group of the Manufacturers Association of Nigeria (PMG-MAN) to achieve 70 per cent local drug production deserves national attention. It is not merely an industry target. It is a strategic national mission. At the centre of this campaign is a bold vision — to move Nigeria from a country that imports most of its pharmaceutical needs to one capable of producing the majority of its medicines locally. That vision may sound ambitious, but history shows that nations only achieve industrial transformation when they dare to think beyond their limitations.

India did not become one of the world’s pharmaceutical leaders by accident. China did not emerge as a global manufacturing powerhouse through dependency. These countries invested deliberately in local production, industrial infrastructure and strategic protection for indigenous industries. Nigeria must now embrace the same mindset. This is why the 2026 Nigeria Pharma Manufacturers Expo comes at such a critical moment.

The expo is more than a gathering of pharmaceutical stakeholders. It represents a strategic platform for shaping the future of local drug manufacturing in Nigeria and across Africa. It is where conversations around industrial growth, healthcare sovereignty, innovation and regional competitiveness intersect. With more than 200 exhibitors and nearly 10,000 healthcare and pharmaceutical professionals expected to participate, the event reflects the growing momentum within Nigeria’s pharmaceutical ecosystem.

But beyond the impressive numbers lies something even more important — hope. Hope that Nigeria can finally build a pharmaceutical sector capable of meeting local demand sustainably. Hope that indigenous manufacturers can compete effectively not just within Nigeria but across Africa. Hope that future healthcare emergencies will not leave the country helplessly dependent on external suppliers.

The theme of this year’s expo, “Regional Manufacturing: Advancing Africa’s Pharma and Life Science Sovereignty through Localisation,” could not have come at a better time.

Africa’s healthcare future cannot continue to depend almost entirely on imported products. A continent with over a billion people must begin to build stronger regional manufacturing capabilities capable of supporting its healthcare systems. Nigeria is strategically positioned to lead that transition. With its large population, expanding market and entrepreneurial energy, the country possesses enormous pharmaceutical potential. Yet potential alone is never enough. Potential without deliberate investment remains unrealised possibility.

This is where PMG-MAN’s advocacy becomes significant. The group’s push for local manufacturing is not simply about economics. It is about national resilience. It is about reducing vulnerability. It is about ensuring that Nigerians have reliable access to affordable and quality medicines regardless of global disruptions. Recent geopolitical tensions and supply chain challenges have only strengthened the urgency of this mission. From the COVID-19 pandemic to international shipping crises and trade uncertainties, the world has witnessed how fragile global supply chains can become during periods of instability. Countries that lacked strong local manufacturing capabilities found themselves struggling for access to essential medical products.

Nigeria cannot afford to remain exposed to such vulnerabilities indefinitely. The encouraging reality is that progress is already visible. New pharmaceutical factories are emerging across the country. More companies are investing in local production. Interest in PMG-MAN membership continues to grow, reflecting rising confidence in the sector. This momentum must not be wasted.

Government policies must now align more aggressively with the vision of pharmaceutical independence. Indigenous manufacturers require access to affordable financing, stable infrastructure and supportive regulations. Local production cannot thrive in an environment burdened by high energy costs, unstable power supply and excessive operational challenges. There must also be stronger protection against the influx of substandard imports that undermine local manufacturers and threaten public health.

At the same time, pharmaceutical companies themselves must embrace innovation and global best practices. The future of pharmaceutical manufacturing is increasingly driven by technology, research and quality assurance. Nigeria’s ambition for pharmaceutical independence must therefore be matched by investments in modern production systems, research capacity and workforce development. The Nigeria Pharma Manufacturers Expo offers an opportunity to accelerate these conversations and convert them into measurable action.

Exhibitions of this nature are important because they bring together policymakers, manufacturers, investors, researchers and healthcare professionals under one platform. They create opportunities for partnerships, technology transfer and strategic collaboration capable of transforming industries.

More importantly, they help shape national consciousness around the importance of local manufacturing.

Nigeria’s pharmaceutical future cannot continue to be built primarily on imports. No country truly develops by depending excessively on external production for critical sectors tied directly to public health and national security. The battle for pharmaceutical independence is therefore not just PMG-MAN’s battle. It is Nigeria’s battle. It is a battle for economic strength. A battle for healthcare security. A battle for industrial relevance. And ultimately, a battle for national dignity.

The good news is that Nigeria already possesses many of the ingredients required for success — market size, human talent, entrepreneurial capacity and growing industrial interest. What remains essential is sustained commitment. Commitment from government. Commitment from industry. Commitment from investors. And commitment from Nigerians themselves to support indigenous manufacturing.

The road ahead will not be without challenges. Industrial transformation never happens overnight. But nations that succeed are often those willing to make difficult investments today for long-term national gain tomorrow. As the 2026 Nigeria Pharma Manufacturers Expo approaches, it should serve not merely as an annual industry event but as a reminder that Nigeria stands at a defining moment. The country can either continue along the path of dependency and vulnerability or embrace the harder but more rewarding journey toward pharmaceutical independence. PMG-MAN has chosen its side in that battle. Nigeria must now decide whether it is ready to win it.